Pujia Roberta, Maurotti Samantha, Coppola Adriana, Romeo Stefano, Pujia Arturo, Montalcini Tiziana
Department of Health Science, University Magna Grecia, Catanzaro,Italy.
Department of Medical and Surgical Science, University Magna Grecia, Catanzaro,Italy.
Curr Diabetes Rev. 2022;18(1):e051021196983. doi: 10.2174/1573399817666211005093434.
Although hyperglycaemia is known to be the leading cause of diabetic complications, the beneficial effect of optimal glucose control in preventing diabetic complications is still far from being proven. In fact, such complications may not be related to glycaemic control alone.
This review summarizes several studies that suggest that a C-peptide deficiency could be new and common pathophysiology for complications in type 1 diabetes, including sexual and reproductive dysfunction.
We reviewed in vitro, in vivo, and human studies on the association between C-peptide deficiency or C-peptide replacement therapy and complications in type 1 diabetes. It seems that Cpeptide replacement therapy may interrupt the connection between diabetes and sexual/reproductive dysfunction.
The Diabetes Control and Complications Trial suggested that maintaining C-peptide secretion is associated with a reduced incidence of retinopathy, nephropathy, and hypoglycaemia. Risk of vascular, hormonal, and neurologic damage in the structures supplying blood to the penis increases with increasing levels of HbA1. However, several human studies have suggested an association between C-peptide production and hypothalamic/pituitary functions. When exposed to C-peptide, cavernosal smooth muscle cells increase the production of nitric oxide. C-peptide in diabetic rats improves sperm count, sperm motility, testosterone levels, and nerve conduction compared to non-treated diabetic rats.
C-peptide deficiency may be involved, at least partially, in the development of several pathological features associated with type 1 diabetes, including sexual/reproductive dysfunction. Preliminary studies have reported that C-peptide administration protects against diabetic microand macrovascular damages as well as sexual/reproductive dysfunction. Therefore, further studies are needed to confirm these promising findings.
尽管高血糖是糖尿病并发症的主要原因,但最佳血糖控制在预防糖尿病并发症方面的有益作用仍远未得到证实。事实上,此类并发症可能并非仅与血糖控制有关。
本综述总结了多项研究,这些研究表明C肽缺乏可能是1型糖尿病并发症(包括性和生殖功能障碍)新的常见病理生理学机制。
我们回顾了关于C肽缺乏或C肽替代疗法与1型糖尿病并发症之间关联的体外、体内和人体研究。似乎C肽替代疗法可能会中断糖尿病与性/生殖功能障碍之间的联系。
糖尿病控制与并发症试验表明,维持C肽分泌与视网膜病变、肾病和低血糖的发生率降低有关。随着糖化血红蛋白水平的升高,阴茎供血结构中血管、激素和神经损伤的风险增加。然而,多项人体研究表明C肽产生与下丘脑/垂体功能之间存在关联。当暴露于C肽时,海绵体平滑肌细胞会增加一氧化氮的产生。与未治疗的糖尿病大鼠相比,糖尿病大鼠体内的C肽可改善精子数量、精子活力、睾酮水平和神经传导。
C肽缺乏可能至少部分参与了与1型糖尿病相关的几种病理特征的发展,包括性/生殖功能障碍。初步研究报告称,给予C肽可预防糖尿病微血管和大血管损伤以及性/生殖功能障碍。因此,需要进一步研究来证实这些有前景的发现。